Date: 2016-03-26
Type of information: Nomination
Compound:
Company: Medivation (USA - CA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On March 28, 2016, Medivation announced that healthcare investment banking veteran Jennifer Jarrett will join Medivation as its new Chief Financial Officer (CFO) on April 23, 2016, succeeding current CFO Rick Bierly who will retire on July 15, 2016. Jennifer Jarrett joins Medivation from Citigroup, where she was Managing Director responsible for building and managing Citigroup's West Coast life sciences and biotechnology investment banking group. Prior to Citigroup, Ms. Jarrett was a Managing Director in Credit Suisse's Health Care Group focused on the biotechnology sector. She earned a bachelor's degree in economics, Cum Laude, from Dartmouth College and holds a master's of business administration from Stanford University Graduate School of Business.
Financial terms:
Latest news:
